The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 20, 2022
Filed:
Mar. 18, 2019
Applicant:
Ariad Pharmaceuticals, Inc., Cambridge, MA (US);
Inventors:
Sharon Bowen, Cambridge, MA (US);
Michael Hanley, Cambridge, MA (US);
David Kerstein, Cambridge, MA (US);
Karthik Venkatakrishnan, Cambridge, MA (US);
Assignee:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/675 (2006.01); A61P 35/04 (2006.01); A61K 9/00 (2006.01); A61K 31/519 (2006.01); A61K 31/573 (2006.01); A61K 31/704 (2006.01); A61K 31/7048 (2006.01); A61K 31/7068 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/675 (2013.01); A61P 35/04 (2018.01); A61K 9/0053 (2013.01); A61K 31/519 (2013.01); A61K 31/573 (2013.01); A61K 31/704 (2013.01); A61K 31/7048 (2013.01); A61K 31/7068 (2013.01); A61K 45/06 (2013.01);
Abstract
Provided herein are methods for treating cancers (e.g., inflammatory myofibroblastic tumor, anaplastic large cell lymphoma, and neuroblastoma) in pediatric patients using brigatinib, as monotherapy or combination therapy with one or more second therapeutic agents.